Macleods Pharmaceuticals Limited recalls 32 lots of the popular blood pressure drug after finding traces of a likely carcinogen. The reconstituted losartan / potassium / hydrochlorothiazide combination tablets contain small amounts of N-nitrosodiethylamine or NDEA, according to a company announcement published on the Food and Drug Administration website on Wednesday.
"Based on the available information, the risk of developing cancer in several patients after prolonged use of the product can not be ruled out", is stated in the Recall Notice
The active ingredient is manufactured by Hetero Labs Limited in India, one of the overseas drug factories associated with recurrent recurrent blood products last July
Macleods also recalled one lot of the losartan combination in February for the same reason.The company said in a statement that for this "she not received " MacBook Pro recalled: Apple voluntarily pulled out MacBook Pro laptops due to a safety risk Reminder of Rock & The diet has always been cited as a major plan to reduce the number of babies born after the reported death
Promoted by the National Institute of Heart, Lung and Blood, blood pressure, improving heart health and weight loss.
Medical specialists advise patients to consult with doctors or pharmacists before interrupting one of the listed blood pressure medications or finding alternative treatment.
Users with medical issues or report an unwanted event may contact Macleods at 855-926-3384 from 8 to 17 hours. EST.
For product queries, contact Qualanex by email at @ qualanex.com or call 888-280-2046 from 07:00 to 16:00.
Was your medicine mentioned?
Here are the doses, batch numbers and leakage dates of said drug:
Losartan potassium tablets 50 mg:
- BLl711A, BLl710A, November 2019
Losartan potassium and tablets hydrochlorothiazide 50 mg / , 5 mg:
- BLK719A, BLK720A, BLK721A, BLK722A, BLK723A, BLK722A, September 2019
- BLK804A, BLK806A, January 2020
Losartan potassium and hydrochlorothiazide tablets 100 mg / 12.5
- BLM716A, BLM720A, August 2019
- BLM719A, BLM720A, August 2019
- BLM721A, BLM722A, September 2019
- BLM802A, BLM803A, December 2019
- BLM825A, BLM826A, BLM827A , September 2021
Contribution: Ken Alutcker
Follow Kelly Tico on Twitter: @KellyTyko
Read or Share this story: h ttps: //www.usatoday.com/story/money/2019/ 06/26 / losartan-recall-2019-blood-pressure-drug-recalled-cancer-risk / 1578603001 /